This document is an excerpt from the EUR-Lex website
Document 62018TN0642
Case T-642/18: Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopimed)
Case T-642/18: Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopimed)
Case T-642/18: Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopimed)
IO C 4, 7.1.2019, p. 36–37
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
7.1.2019 |
EN |
Official Journal of the European Union |
C 4/36 |
Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopimed)
(Case T-642/18)
(2019/C 4/48)
Language of the case: English
Parties
Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Faes Farma, SA (Lamiaco-Leioa, Spain)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: Application for European Union word mark DermoFaes Atopimed — Application for registration No 15 069 396
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 11 July 2018 in Case R 1365/2017-2
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
uphold the opposition and reject the contested application; |
|
— |
order EUIPO and, as the case may be, the intervener to bear the costs of the proceedings and the costs incurred by proceedings before EUIPO. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |